Biomedical Catalyst 2020: Providing ‘hugely important’ funding opportunities for UK medtech SMEs
Oxford-based firm Sense Biodetection secured more than £1.7m for its influenza and RSV diagnostic test in 2018 (Credit: Sense Biodetection)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X